Remedy Entertainment

26,1EUR +0,77 %
11 048 investerare följer bolaget.

Remedy Entertainment är en spelutvecklare. Verksamheten är främst inriktad mot utveckling av actionspel, med särskilt fokus på 3D-teknik. Exempel på spel som bolaget utvecklat inkluderar ett flertal olika versioner av Alan Wake, Max Payne, samt Death Rally. Idag återfinns spelen främst på den nordiska marknaden. Bolagets huvudkontor ligger i Esbo.

P/E (23e)
−29,66
EV/EBIT (23e)
−26,91
P/B (23e)
4,68
Direktavkastnings- % (23e)
0,38 %
Riktkurs
25.00 EUR
Rekommendation
Öka
Uppdaterad
26.4.2023
NASDAQ Helsinki
REMEDY
Dagens lägsta / högsta pris
24,85 / 26,3 EUR
Börsvärde
351,57 mn EUR
Omsättning
272,4 tn EUR
Volym
11 tn
Risk och rekommendation
HögRiskLåg
SäljRekommendationKöp

Resultaträkning

20192020202120222023e2024e2025e2026e
Omsättning31,6541,0944,7343,5936,3162,1066,1088,50
tillväxt-%57,08 %29,83 %8,86 %−2,54 %−16,70 %71,02 %6,44 %33,89 %
EBITDA7,3613,9514,451,91−8,7514,0416,3333,71
EBIT6,537,2511,41−0,56−11,756,838,6622,69
EBIT6,537,2511,41−0,56−11,756,838,6622,69
Vinst före skatt6,567,0311,34−1,19−11,866,738,5622,59
Nettoresultat5,245,418,79−1,73−11,865,386,8518,07
EPS0,430,450,67−0,13−0,880,400,501,31
tillväxt-%884,20 %3,33 %50,06 %−119,08 %26,26 %162,11 %
Utdelning0,110,160,170,100,100,170,170,25
Utdelningskvot25,35 %36,23 %25,71 %−77,92 %−11,36 %42,82 %33,92 %19,03 %

Lönsamhet och avkastning på kapital

20192020202120222023e2024e2025e2026e
EBITDA-%23,25 %33,96 %32,31 %4,37 %−24,10 %22,61 %24,70 %38,09 %
EBIT-%20,65 %17,64 %25,50 %−1,29 %−32,36 %11,00 %13,10 %25,64 %
EBIT-%20,65 %17,64 %25,50 %−1,29 %−32,36 %11,00 %13,10 %25,64 %
ROE21,49 %17,32 %14,24 %−1,96 %−14,50 %6,98 %8,40 %19,73 %
ROI23,61 %20,17 %17,14 %−0,62 %−14,02 %8,73 %10,49 %24,48 %

Värdering

20192020202120222023e2024e2025e2026e
Pris per aktie (EUR)11,4539,0039,7021,8526,1026,1026,1026,10
Aktier12,0712,0713,3013,4513,4713,5613,6613,76
Börsvärde138,23470,82527,95293,85351,57354,02356,46359,07
Rörelsevärde122,35452,82473,29240,99316,20316,40314,31298,39
EV/S3,8711,0210,585,538,715,104,763,37
EV/EBITDA16,6332,4532,75126,51-22,5319,258,85
EV/EBIT18,7262,4841,49--46,3236,3113,15
EV/EBIT18,7262,4841,49--46,3236,3113,15
P/E (just.)26,3986,9959,01--65,7552,0719,87
P/E26,3986,9959,01--65,7552,0719,87
P/B5,2413,046,043,334,684,474,263,61
P/S4,3711,4611,806,749,685,705,394,06
Direktavkastning0,96 %0,42 %0,43 %0,46 %0,38 %0,65 %0,65 %0,96 %
Soliditet73,50 %70,39 %86,45 %88,75 %90,38 %88,38 %88,37 %88,06 %
Gearing ratio−60,18 %−49,84 %−62,53 %−59,82 %−47,06 %−47,50 %−50,34 %−60,99 %

Quarter data

Q2/22Q3/22Q4/222022Q1/23Q2/23eQ3/23eQ4/23e2023e
Omsättning9,407,9113,6243,596,918,3010,1011,0036,31
EBITDA−1,81−2,412,791,91−4,95−3,00−1,000,20−8,75
EBIT−2,41−3,032,12−0,56−5,60−3,65−1,65−0,85−11,75
Vinst före skatt−2,94−3,152,19−1,19−5,63−3,68−1,68−0,88−11,86
Nettoresultat−2,72−2,661,48−1,73−5,63−3,68−1,68−0,88−11,86
Publisher
Remedy’s Alan Wake 2 will be released on October 17

Remedy and Epic Games announced a brand new trailer for Alan Wake 2 at Wednesday's Playstation Showcase event and that the game will be released on Tuesday October 17, 2023. More information about the game can be found in Remedy's press release and on Alan Wake’s website, where the game is also available for pre-order. Based on a quick review, initial reactions to the trailer from players on social media seem largely positive.

Analytikerkommentar2023-05-25 av Atte Riikola
Publisher
Remedy: Excitement builds ahead of AW2 release

Remedy's Q1 figures were weak as expected, with the company's 5 game projects in development this year mainly showing up as costs in the income statement. However, the company's investment story is about to enter an interesting phase with the release of Alan Wake 2 at the end of the year, which will also be a key short-term driver for the stock.

Aktieanalys2023-04-27 av Atte Riikola
Publisher
Remedy Q1 morning result: Developments in line with expectations early in the year

As expected, Remedy's Q1 results reported this morning were clearly in the red, with low development fees recorded in the early part of the year due to timing factors. The company is still clearly in the investment phase this year, with five game projects under development. The most important thing to hear at this point was that projects have been progressing since the beginning of the year and that the release of Alan Wake 2 later this year is getting very close.

Analytikerkommentar2023-04-26 av Atte Riikola
Publisher
Remedy Q1 next Wednesday: In the investment phase

We have made changes to our quarterly estimates ahead of Remedy's Q1 report on April 26 at 9.00 am. On an annual basis, our estimates are largely unchanged, and this year Remedy is still in a clear investment phase as the company builds its strategy for the next phase of growth with 5 major game projects under development.

Aktieanalys2023-04-19 av Atte Riikola
Publisher
Remedy: Towards the AW2 release in a cautiously positive mood

There were no major surprises in the company's Q4 figures and, as expected, the outlook for 2023 is still weak in light of the figures. This year, Remedy is still clearly in an investment phase as the company builds its strategy for the next growth leap with 5 major gaming projects under development.

Aktieanalys2023-02-13 av Atte Riikola
Publisher
Remedy Q4 morning result: As expected, the outlook foresees a year of investment before the start of earnings growth phase

Remedy reported slightly better-than-expected Q4 figures this morning. Based on the outlook, the company's revenue and earnings are expected to decline this year, ahead of the earnings growth phase that will start with the release of Alan Wake 2 at the end of the year.

Analytikerkommentar2023-02-10 av Atte Riikola